Oritavancin Diphosphate + Warfarin Interaction
Moderateinteraction on record
Description
Oritavancin is a weak CYP2C9 inhibitor. Although a study showed no effect on S-warfarin pharmacokinetics, patients should be monitored closely for bleeding when concomitantly receiving oritavancin and warfarin.
Mechanism
Weak CYP2C9 inhibition
Source: NLP:oritavancin diphosphate